
Results
4
Big ticket companies showing a potential underpricing based on intrinsic value
4 companies
AstraZeneca
Market Cap: UK£193.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£127.02
7D
1.1%
1Y
19.0%
GSK
Market Cap: UK£75.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.11
7D
-0.3%
1Y
39.3%
Haleon
Market Cap: UK£32.5b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.66
7D
1.9%
1Y
2.1%
Hikma Pharmaceuticals
Market Cap: UK£3.2b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£15.69
7D
4.9%
1Y
-21.4%